Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil- active cytokines

Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cyto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory cell and molecular biology 1997-04, Vol.16 (4), p.455-463
Hauptverfasser: Okada, S, Kita, H, George, TJ, Gleich, GJ, Leiferman, KM
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 463
container_issue 4
container_start_page 455
container_title American journal of respiratory cell and molecular biology
container_volume 16
creator Okada, S
Kita, H
George, TJ
Gleich, GJ
Leiferman, KM
description Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1alpha, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by beta1- and beta2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.
doi_str_mv 10.1165/ajrcmb.16.4.9115757
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78951398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78951398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-6b12a1877bcc3021223bc9e1dfeaef64a83710cc9e812015b7229227b865dd363</originalsourceid><addsrcrecordid>eNpdkd-K1TAQxoso67r6BCIEL8SbHjtJ0zbeyeI_WPBmvQ5pOm1zbJKapCvnaXxV456i4lWG-X7zzYSvKJ5DdQBo-Bt1DNr2B2gO9UEA8Ja3D4pL4IyXtejEw1xXdV0Cr8Xj4kmMx6oC2gFcFBc7fln8vA3KRWumoJLxjviRoI_G-XU2SyRpDn6bZtKriBZdIhZtnyeQaG9X73IrEuPInUnBvyXx5DBMJiajCY4j6qxmx3VRCRdMpdLJ3OVFbiJjrn0gyg3_LCzJPZHdT8l_Mw7j0-LRqJaIz_b3qvj64f3t9afy5svHz9fvbkpd0yaVTQ9UQde2vdasokAp67VAGEZUODa16lgLlc6tDmgFvG8pFZS2fdfwYWANuypenX3X4L9vGJO0JmpclvxXv0XZdoIDE10GX_4HHv0WXL5N0qpteCeYyBA7Qzr4GAOOcg3GqnCSUMnf2clzdhIaWcs9jDz1YrfeeovDn5m_-uuzPptp_mECymjVsmQadr97u5pz9gs8fKj4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>207658939</pqid></control><display><type>article</type><title>Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil- active cytokines</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Okada, S ; Kita, H ; George, TJ ; Gleich, GJ ; Leiferman, KM</creator><creatorcontrib>Okada, S ; Kita, H ; George, TJ ; Gleich, GJ ; Leiferman, KM</creatorcontrib><description>Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1alpha, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by beta1- and beta2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.</description><identifier>ISSN: 1044-1549</identifier><identifier>EISSN: 1535-4989</identifier><identifier>DOI: 10.1165/ajrcmb.16.4.9115757</identifier><identifier>PMID: 9115757</identifier><identifier>CODEN: AJRBEL</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>Basement Membrane - cytology ; Cell Adhesion Molecules - physiology ; Chemotactic Factors - pharmacology ; Chemotaxis, Leukocyte - drug effects ; Collagen ; Cytokines - pharmacology ; Drug Combinations ; Eosinophils - cytology ; Humans ; Kinetics ; Laminin ; Platelet Activating Factor - pharmacology ; Proteoglycans</subject><ispartof>American journal of respiratory cell and molecular biology, 1997-04, Vol.16 (4), p.455-463</ispartof><rights>Copyright American Thoracic Society Apr 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-6b12a1877bcc3021223bc9e1dfeaef64a83710cc9e812015b7229227b865dd363</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9115757$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okada, S</creatorcontrib><creatorcontrib>Kita, H</creatorcontrib><creatorcontrib>George, TJ</creatorcontrib><creatorcontrib>Gleich, GJ</creatorcontrib><creatorcontrib>Leiferman, KM</creatorcontrib><title>Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil- active cytokines</title><title>American journal of respiratory cell and molecular biology</title><addtitle>Am J Respir Cell Mol Biol</addtitle><description>Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1alpha, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by beta1- and beta2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.</description><subject>Basement Membrane - cytology</subject><subject>Cell Adhesion Molecules - physiology</subject><subject>Chemotactic Factors - pharmacology</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Collagen</subject><subject>Cytokines - pharmacology</subject><subject>Drug Combinations</subject><subject>Eosinophils - cytology</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Laminin</subject><subject>Platelet Activating Factor - pharmacology</subject><subject>Proteoglycans</subject><issn>1044-1549</issn><issn>1535-4989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkd-K1TAQxoso67r6BCIEL8SbHjtJ0zbeyeI_WPBmvQ5pOm1zbJKapCvnaXxV456i4lWG-X7zzYSvKJ5DdQBo-Bt1DNr2B2gO9UEA8Ja3D4pL4IyXtejEw1xXdV0Cr8Xj4kmMx6oC2gFcFBc7fln8vA3KRWumoJLxjviRoI_G-XU2SyRpDn6bZtKriBZdIhZtnyeQaG9X73IrEuPInUnBvyXx5DBMJiajCY4j6qxmx3VRCRdMpdLJ3OVFbiJjrn0gyg3_LCzJPZHdT8l_Mw7j0-LRqJaIz_b3qvj64f3t9afy5svHz9fvbkpd0yaVTQ9UQde2vdasokAp67VAGEZUODa16lgLlc6tDmgFvG8pFZS2fdfwYWANuypenX3X4L9vGJO0JmpclvxXv0XZdoIDE10GX_4HHv0WXL5N0qpteCeYyBA7Qzr4GAOOcg3GqnCSUMnf2clzdhIaWcs9jDz1YrfeeovDn5m_-uuzPptp_mECymjVsmQadr97u5pz9gs8fKj4</recordid><startdate>19970401</startdate><enddate>19970401</enddate><creator>Okada, S</creator><creator>Kita, H</creator><creator>George, TJ</creator><creator>Gleich, GJ</creator><creator>Leiferman, KM</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19970401</creationdate><title>Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil- active cytokines</title><author>Okada, S ; Kita, H ; George, TJ ; Gleich, GJ ; Leiferman, KM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-6b12a1877bcc3021223bc9e1dfeaef64a83710cc9e812015b7229227b865dd363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Basement Membrane - cytology</topic><topic>Cell Adhesion Molecules - physiology</topic><topic>Chemotactic Factors - pharmacology</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Collagen</topic><topic>Cytokines - pharmacology</topic><topic>Drug Combinations</topic><topic>Eosinophils - cytology</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Laminin</topic><topic>Platelet Activating Factor - pharmacology</topic><topic>Proteoglycans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okada, S</creatorcontrib><creatorcontrib>Kita, H</creatorcontrib><creatorcontrib>George, TJ</creatorcontrib><creatorcontrib>Gleich, GJ</creatorcontrib><creatorcontrib>Leiferman, KM</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory cell and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okada, S</au><au>Kita, H</au><au>George, TJ</au><au>Gleich, GJ</au><au>Leiferman, KM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil- active cytokines</atitle><jtitle>American journal of respiratory cell and molecular biology</jtitle><addtitle>Am J Respir Cell Mol Biol</addtitle><date>1997-04-01</date><risdate>1997</risdate><volume>16</volume><issue>4</issue><spage>455</spage><epage>463</epage><pages>455-463</pages><issn>1044-1549</issn><eissn>1535-4989</eissn><coden>AJRBEL</coden><abstract>Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1alpha, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by beta1- and beta2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>9115757</pmid><doi>10.1165/ajrcmb.16.4.9115757</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-1549
ispartof American journal of respiratory cell and molecular biology, 1997-04, Vol.16 (4), p.455-463
issn 1044-1549
1535-4989
language eng
recordid cdi_proquest_miscellaneous_78951398
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Basement Membrane - cytology
Cell Adhesion Molecules - physiology
Chemotactic Factors - pharmacology
Chemotaxis, Leukocyte - drug effects
Collagen
Cytokines - pharmacology
Drug Combinations
Eosinophils - cytology
Humans
Kinetics
Laminin
Platelet Activating Factor - pharmacology
Proteoglycans
title Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil- active cytokines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A30%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transmigration%20of%20eosinophils%20through%20basement%20membrane%20components%20in%20vitro:%20synergistic%20effects%20of%20platelet-activating%20factor%20and%20eosinophil-%20active%20cytokines&rft.jtitle=American%20journal%20of%20respiratory%20cell%20and%20molecular%20biology&rft.au=Okada,%20S&rft.date=1997-04-01&rft.volume=16&rft.issue=4&rft.spage=455&rft.epage=463&rft.pages=455-463&rft.issn=1044-1549&rft.eissn=1535-4989&rft.coden=AJRBEL&rft_id=info:doi/10.1165/ajrcmb.16.4.9115757&rft_dat=%3Cproquest_cross%3E78951398%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=207658939&rft_id=info:pmid/9115757&rfr_iscdi=true